Intérêt de l’entreprise et choix stratégiques : les licences concédées par Gilead au Medicines Patent Pool 14/03/2012 by Intellectual Property Watch Leave a Comment Bien que Gilead ait apporté des améliorations considérables à ses précédentes licences volontaires portant sur des médicaments antirétroviraux essentiels, les licences que l’entreprise a concédées au Medicines Patent Pool, fondation créée par UNITAID, comportent des restrictions regrettables qui fragilisent leur impact sur l’accès à des antirétroviraux génériques de qualité garantie plus abordables dans les pays en développement.
WIPO To Discuss Role Of Patents In Access To Water 14/03/2012 by Intellectual Property Watch 1 Comment The World Intellectual Property Organization has waded into the global debates over access to safe drinking water, with an upcoming workshop on patents and water purification technologies.
US Aims To Boost Its Efforts Against Overseas Infringers 13/03/2012 by Steven Seidenberg for Intellectual Property Watch 1 Comment US President Barack Obama wants the country’s Justice Department to get by with a bit less money next fiscal year – but not when it comes to prosecuting overseas infringers of American IP rights.
WHO Under Siege By Private Sector, Group Asserts 13/03/2012 by Intellectual Property Watch Leave a Comment The World Health Organization is under siege by private sector forces using their financial leverage to gain undue influence in the financially beleaguered United Nations agency, a developing country-oriented group has said.
India Grants First Compulsory Licence, For Bayer Cancer Drug 12/03/2012 by Maricel Estavillo for Intellectual Property Watch 8 Comments In a move welcomed by many in the international community, India has granted an application, its first, from a homegrown generic drug maker to manufacture and sell a patented cancer drug under a compulsory licence.
European High Court Hears Case With Impact On Buying Software Online 08/03/2012 by Maricel Estavillo for Intellectual Property Watch Leave a Comment The European Court of Justice (ECJ) this week held a public hearing on a German case involving software companies Oracle and UsedSoft, the second step to a ruling that could potentially set new rules for buying and downloading software on the internet.
US Congressman Posts ACTA For Open Debate 07/03/2012 by Intellectual Property Watch 1 Comment A United States congressional representative has posted the text of the controversial Anti-Counterfeiting Trade Agreement (ACTA) to the internet and is calling for public comments out of the fear that the agreement will harm the open internet.
WIPO Sets Record For International Patent Filings In 2011; LDCs Not A Factor 05/03/2012 by William New, Intellectual Property Watch Leave a Comment The World Intellectual Property Organization today announced that it had set a new record for filings of patents at the international level in 2011, in what the UN agency attributed to a focus on innovation. Patents filed under the WIPO-managed Patent Cooperation Treaty shot up more than 10 per cent last year in the fastest growth since 2005, and a Chinese company took top honour for most filings.
Internet Governance In 2012: Reaching New Heights Or Hitting A Wall 05/03/2012 by Monika Ermert for Intellectual Property Watch Leave a Comment There will be more than 50 important meetings talking internet in 2012, and activists and government alike have started calling for streamlining or better cooperation and focus. Yet what might make 2012 a very notable year with regard to the politics of the net is not these meetings, but the rising storms blowing over the net regarding day to day internet politics. The preliminary stop of the un-beloved SOPA/PIPA legislation in the United States and the unexpected hesitation of Europe to sign the controversial ACTA agreement gave a first taste of a hot year in internet governance.
European Parliament Hears Pitch For ACTA; But Did It Change Minds? 02/03/2012 by Dugie Standeford for Intellectual Property Watch 1 Comment The controversial Anti-Counterfeiting Trade Agreement consumed hours of European Parliament time this week as the European Commission sought to persuade lawmakers to approve it. But no matter how often EC officials, academics and lawyers said the treaty will not change EU law, scepticism still remains about its potential impact on digital freedoms and access to generic medicines in developing countries – including from the Parliament member who will author the legislative report.